Genetic Signatures Limited
GSS
Rank in Stocks
#28145
Genetic Signatures Limited operates as a molecular diagnostics (MDx)... Genetic Signatures Limited operates as a molecular diagnostics (MDx) enterprise, extending its reach across Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. The company engineers and manufactures an array of real-time Polymerase Chain Reaction (PCR)-based products, sold under the EasyScreen brand, for the identification of infectious diseases. Moreover, it offers its proprietary MDx 3Base platform technology, enabling hospitals and pathology laboratories to conduct comprehensive screenings for diverse infectious pathogens. Its offerings also encompass detection kits tailored for conditions such as gastrointestinal ailments, respiratory illnesses, sexual health concerns, antimicrobial resistance, meningitis, and tropical diseases. Founded in 2001, the firm is headquartered in Newtown, Australia.
Share Price
$0.05329863
Last synced: 2026-11-09
Market Cap
$12.11M
Change (1 day)
13.24%
Change (1 year)
-75.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genetic Signatures Limited (GSS)
Category
Healthcare
Operating Margin for Genetic Signatures Limited (GSS)
Operating Margin as of November 2026 TTM: -122.76%
According to Genetic Signatures Limited's latest financial reports, its current operating margin (TTM) is -122.76%. At the end of 2025 the company had an operating margin of -116.23%.
Operating Margin history for Genetic Signatures Limited from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -122.76% | 5.62% |
| 2025 | -116.23% | -49.17% |
| 2024 | -228.68% | 105.06% |
| 2023 | -111.52% | -1,430.79% |
| 2022 | 8.38% | 52.36% |
| 2021 | 5.50% | -112.83% |
| 2020 | -42.88% | -16.32% |
| 2019 | -51.24% | -24.70% |
| 2018 | -68.05% | -0.69% |
| 2017 | -68.52% | -25.36% |
| 2016 | -91.80% | -69.17% |
| 2015 | -297.78% | 211.68% |
| 2014 | -95.54% | -89.14% |
| 2013 | -879.85% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.15% |
US
|
|
| 20.38% | -100.17% |
US
|
|
| 43.02% | -100.35% |
CN
|
|
| 32.03% | -100.26% |
US
|
|
| 22.23% | -100.18% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Genetic Signatures Limited's operating margin
What is Genetic Signatures Limited's operating margin?
Genetic Signatures Limited's operating margin is -122.76%, as of Nov 2026.
What was Genetic Signatures Limited's operating margin in 2025?
In 2025, Genetic Signatures Limited's operating margin was -116.23%, compared with -228.68% in 2024.
How has Genetic Signatures Limited's operating margin changed since 2020?
From 2020 to 2025, Genetic Signatures Limited's operating margin was highest in 2022 (8.38%) and lowest in 2024 (-228.68%).
How does Genetic Signatures Limited's operating margin compare with similar companies?
Genetic Signatures Limited's operating margin (-122.76%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.